AMY ORREGO: Open Payments
NPI 1558844746 · MORRISTOWN, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$944 in 37 payments from 15 companies in 2025. Trend: 2023 $644 · 2024 $828 · 2025 $944
Food & beverage: $944
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 9 | $311 |
| ABIOMED | 1 | $146 |
| PFIZER INC. | 4 | $65 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $62 |
| Novartis Pharmaceuticals Corporation | 3 | $61 |
| E.R. Squibb & Sons, L.L.C. | 3 | $43 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $42 |
| HEARTFLOW, INC. | 2 | $41 |
| Novo Nordisk Inc | 2 | $37 |
| Boston Scientific Corporation | 1 | $33 |
Products named: Repatha, JARDIANCE, ELIQUIS, LEQVIO, Kerendia, FFRct, Wegovy, VYNDAQEL.
Industry payments across NJ — which companies pay providers there.
